Analysis of the VCD Protocol (bortezomib, Cyclophosphamide, and Dexamethasone) in the Treatment of Multiple Myeloma. RSD 2023, 12 (13), e42121344144. https://doi.org/10.33448/rsd-v12i13.44144.